| Professor Jan Löwe | |||||||||||||||
| Birth Date: | 14 July 1967 | ||||||||||||||
| Nationality: | German | ||||||||||||||
| Term Start1: | 2018 | ||||||||||||||
| Predecessor1: | Sir Hugh Pelham | ||||||||||||||
| Module: |
| ||||||||||||||
Jan Löwe (born 14 July 1967) is a German molecular and structural biologist and the Director of the Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) in Cambridge, UK. He became Director of the MRC-LMB in April 2018,[1] succeeding Sir Hugh Pelham. Löwe is known for his contributions to the current understanding of bacterial cytoskeletons.[2]
Löwe was awarded a Diploma in Chemistry by the University of Hamburg in 1992. He was then awarded his Dr. rer. nat. in 1995 by the Technische Universität München, for his thesis work on the structure of the proteasome[3] completed at the Max Planck Institute of Biochemistry under the supervision of Robert Huber.
Löwe worked briefly as a postdoctoral researcher at the Max Planck Institute of Biochemistry,[4] before moving to MRC-LMB in 1996 to take up an EMBO long-term fellowship to work on crystallising FtsZ, a bacterial homologue of eukaryotic tubulin, with Linda A. Amos.[5] Löwe became a group leader at MRC-LMB in 1998 and was awarded tenure in 2002. His group has largely worked on the structural and molecular biology of prokaryotic cytoskeletons, but has also made important contributions to the current understanding of cell division and DNA partitioning in both prokaryotes and eukaryotes. Löwe became the Director of MRC-LMB in April 2018, having formerly been Deputy Director (2016-18) and Joint Head of the Structural Studies Division at the institute (2010-18).In 2018, the title of Honorary Professor of Structural and Molecular Microbiology at the University of Cambridge wasconferred on him.[6]